Cover Image
Market Research Report
Product code 
1085960

Sepsis Diagnostics Market, by Product Type, by Method, by Pathogen, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published: | Coherent Market Insights | 168 Pages | Delivery time: 2-3 business days

Price

Back to Top
Sepsis Diagnostics Market, by Product Type, by Method, by Pathogen, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Published: May 23, 2022
Coherent Market Insights
Content info: 168 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Sepsis is a condition wherein the body's response to infection trigger an inflammation reaction throughout the body. Immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body but instead these chemicals cause cascade of reactions that result in organ damage and may be fatal. Few of the symptoms of sepsis include low blood pressure, mental confusion, fever, increased heart rate, and difficulty in breathing. Sepsis may be caused by infectious agents such as bacteria, virus, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, use of antibiotics, and usage of invasive medical devices such as catheters.

Market Dynamics

Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2021, Inflammatix, Inc., a U.S. based diagnostics company initiated clinical trial study for their product HostDx Sepsis with 1500 participants which is expected to be completed by November 2021. This clinical study investigates the performance of HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.

Market players are focusing on launch of products, which is expected to strengthen their position in the global sepsis diagnostics market. For instance, in July 2018, Thermo Fisher Scientific Inc., a U.S. based diagnostics solutions provider launched its product B*R*A*H*M*S PCT which is a direct POC (Point of Care) assay for early detection of sepsis.

Market players are involved in expanding their presence globally, by entering into collaboration with other companies in order to enhance distribution, this is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2021, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a U.S. based biomedical testing solutions provider entered into a strategic collaboration for development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.

Key features of the study:

  • This report provides an in-depth analysis of global sepsis diagnostics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global Sepsis Diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include BioMerieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global sepsis diagnostics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sepsis diagnostics market

Detailed Segmentation:

  • Global Sepsis Diagnostics Market, By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • Global Sepsis Diagnostics Market, By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • Global Sepsis Diagnostics Market, By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • Global Sepsis Diagnostics Market, By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Global Sepsis Diagnostics Market, By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • Global Sepsis Diagnostics Market, By Region:
    • North America
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Product Type:
    • Blood Culture Media
    • Assays & Reagents
    • Instruments
    • Software
  • By Method:
    • Automated Diagnostics
    • Conventional Diagnostics
  • By Pathogen:
    • Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • By Technology:
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • By End User:
    • Hospitals
    • Pathology & Reference Laboratories
    • Research Laboratories & Academic Institutes
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • BioMerieux SA*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Roche Diagnostics AG
  • Luminex Corporation
  • CytoSorbents Corporation
  • Becton Dickinson Company
  • Danaher Corporation
  • Axis-Shield Diagnostics
  • T2 Biosystems
  • EKF Diagnostics
  • Immunexpress Inc.
  • Response Biomedical Corporation
  • Bruker Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1166

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Method
    • Market Snippet, By Pathogen
    • Market Snippet, By Technology
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Algorithm for Clinical Approach to Sepsis
  • Associated/Predisposing Factors for and Typical Clinical Signs Of Sepsis
  • PEST Analysis
  • Industry Trends
  • Pipeline Analysis
  • Key Highlights
  • Epidemiology
  • Drugs Pricing List
  • Reimbursement Scenario of Sepsis Diagnostics
  • Regulatory Scenario
  • Global Supply Chain Analysis

4. COVID - 19 Impact Analysis

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Sepsis Diagnostics
  • Impact of Covid-19 on the Sepsis Diagnostics Market

5. Global Sepsis Diagnostics Market, By Product Type, 2017-2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Blood Culture Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Assays & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Sepsis Diagnostics Market, By Method, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Automated Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Conventional Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Sepsis Diagnostics Market, By Pathogen, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Bacterial Sepsis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Sepsis Diagnostics Market, By Technology, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Microbiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Sepsis Diagnostics Market, By End User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Pathology & Reference Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Research Laboratories & Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

10. Global Sepsis Diagnostics Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Method, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Pathogen, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

11. Competitive Landscape

  • Company Profiles
    • BioMerieux SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Roche Diagnostics AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Luminex Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • CytoSorbents Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Becton Dickinson Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Axis-Shield Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • T2 Biosystems
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • EKF Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Immunexpress Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Response Biomedical Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Bruker Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact